APPLICATION
ANDA209784
TYPE
ANDA
ORIGINAL APPROVAL
2017-08-23
LATEST ACTION
2020-11-24
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
EPHEDRINE SULFATEPrescription
EPHEDRINE SULFATE 50MG/ML (50MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2020-11-24Labeling · Supplement 2 · standardAP
2019-10-28Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.